[1]Tan Y R, Sun J C, Lu X Y, Su D M, Zhang J Q. Entry of Bombyx mori cypovirus 1 into midgut cells in vivo. Journal of Electron Microscopy (Tokyo), 2003, 52(5): 485-489.[2]Sun J C, Chen D N, Yang Y F, Zhang Q F, Tan P C, Xu X Y, Qiu B L. Penetration and replication of Bombyx mori cytoplasmic polyhedrosis virus in vivo. Acta Scientiarum Naturalium Universitatis Sunyatseni, 2006, 45(2): 78-82.[3]张建红, 高玮, 张立人. 家蚕质型多角体病毒在蚕体内的形态发生及其细胞病理变化. 蚕业科学, 1990, 16(3): 140-144.Zhang J H, Gao W, Zhang L R. Morphogenesis of cytoplasmic polyhedrsis virus of Bombyx mori in vivo and cytopathologic changes. Acta Sericologica Sinica, 1990, 16(3): 140-144. (in Chinese)[4]钟杨生, 徐秋云, 林健荣, 王叶元, 范兰芬. 高温干燥对家蚕胚胎发育影响的蛋白质表达谱分析//中国蚕学会第六届青年学术研讨会论文集 (2), 2009.Zhong Y S, Xu Q Y, Lin J Y, Wang Y Y, Fan L F. Analysis on protein expression of silkworm embryonic development under high temperature and dry condition//The Sixth Youth Symposium of Chinese Society of Sericultural Science (2), 2009. (in Chinese)[5]裘智勇, 李木旺, 沈兴家, 郭锡杰. 家蚕对浓核病毒 (镇江株)抵抗性和感受性品种的中肠组织蛋白比较分析. 蚕业科学, 2008, 34(2): 244-249.Qiu Z Y, Li M W, Shen X J, Guo X J. Comparative analysis of proteins extracted from midgut of silkworm strains susceptible and non-susceptible to Bomby mori Densovirus (Zhenjiang strain). Acta Sericologica Sinica, 2008, 34(2): 244-249. (in Chinese)[6]刘晓勇, 陈克平, 姚勤, 李军, 蔡克亚. 家蚕中肠组织抗核型多角体病毒病的相关蛋白分析. 昆虫学报, 2008, 51(4): 443-448.Liu X Y, Chen K P, Yao Q, Li J, Cai K Y. Proteome analysis of silkworm (Bombyx mori) midgut proteins related to BmNPV infection resistance or susceptibility. Acta Entomologica Sinica, 2008, 51(4): 443-448. (in Chinese)[7]Qin L G, Xia H C, Shi H F, Zhou Y J, Chen L, Yao Q, Liu X Y, Feng F, Yuan Y, Chen K P. Comparative proteomic analysis reveals that caspase-1 and serine protease may be involved in silkworm resistance to Bombyx mori nuclear polyhedrosis virus. Journal of Proteomics, 2012, 75(12): 3630-3638.[8]Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 1976, 72(1/2): 248-254.[9]Gordaliza M, Castro M A, Miguel del Corral J M, Lopez-Vazquez M L, Garcia P A, Garcia-Gravalos M D, San Feliciano A. Synthesis and antineoplastic activity of cyclolignan aldehydes. European Journal of Medicinal Chemistry, 2000, 35: 691-698.[10]Hoogenboom B W, Suda K, Engel A, Fotiadis D. The supramolecular assemblies of voltage-dependent anion channels in the native membrane. Journal of Molecular Biology, 2007, 370: 246-255.[11]Mannella C A. The ‘ins’ and ‘outs’ of mitochondrial membrane channels. Trends in Biochemical Sciences, 1992, 17: 315-320.[12]Dihanich M. The biogenesis and function of eukaryotic porins. Experientia, 1990, 46: 146-153.[13]Forte M, Guy H R, Mannella C A. Molecular genetics of the VDAC ion channel: structural model and sequence analysis. Journal of Bioenergetics and Biomembranes, 1987, 19(4): 341-350.[14]Hiller S, Abramson J, Mannella C, Wagner G, Zeth K. The 3D structures of VDAC represent a native conformation. Trends in Biochemical Sciences, 2010, 35: 514-521.[15]Shimizu S, Konishi A, Kodama T, Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proceedings of the National Academy of Sciences of the United States of America, 2000, 97(7): 3100-3105.[16]Vander Heiden M G, Chandel N S, Schumacker P T, Thompson C B. Bcl-XL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Molecular Cell, 1999, 3: 159-167.[17]Vander Heiden M G, Li X X, Gottleib E, Hill R B, Thompson C B, Colombini M. Bcl- XL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. Journal of Biological Chemistry, 2001, 276(22): 19414-19419.[18]Shimizu S, Shinohara Y, Tsujimoto Y. Bax and Bcl- xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator. Oncogene, 2000, 19(38): 4309-4318.[19]Tan W, Lai J C, Miller P, Stein C A, Colombini M. Phosphorothioate oligonucleotides reduce mitochondrial outer membrane permeability to ADP. American Journal of Physiology-Cell Physiology, 2007, 292: 1388-1397.[20]Tan W, Loke Y H, Stein C A, Miller P, Colombini M. Phosphorothioate oligonucleotides block the VDAC channel. Biophysical Journal, 2007, 93: 1184-1191.[21]Lai J C, Tan W, Benimetskaya L, Miller P, Colombini M, Stein C A. A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(19): 7494-7499.[22]Tan W, Colombini M. VDAC closure increases calcium ion flux. Biochimica et Biophysica Acta, 2007, 1768: 2510-2515.[23]Peng M, Falk M J, Haase V H, King R, Polyak E, Selak M, Yudkoff M, Hancock W W, Meade R, Saiki R, Lunceford A L, Clarke C F, Gasser D L. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genetics, 2008, 4(4): e1000061.[24]Ziegler C G, Peng M, Falk M J, Polyak E, Tsika E, Ischiropoulos H, Bakalar D, Blendy J A, Gasser D L. Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice. Mitochondrion, 2012, 12: 248-257.[25]Chen P, Zhao S H, Chu Y L, Xu K, Zhu L, Wu Y, Song J, Cao C X, Xue X, Niu Y Y. Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line. Anticancer Drugs, 2009, 20(2): 141-148.[26]Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. Journal of the National Cancer Institute, 2000, 92(16): 1295-1302.[27]Schuetz J D, Connelly M C, Sun D, Paibir S G, Flynn P M, Srinivas R V, Kumar A, Fridland A. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nature Medicine, 1999, 5(9): 1048-1051.[28]Wielinga P R, van der Heijden I, Reid G, Beijnen J H, Wijnholds J, Borst P. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. Journal of Biological Chemistry, 2003, 278(20): 17664-17671.[29]Jedlitschky G, Burchell B, Keppler D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. Journal of Biological Chemistry, 2000, 275(39): 30069-30074.[30]Guo Y, Kotova E, Chen Z S, Lee K, Hopper-Borge E, Belinsky M G, Kruh G D. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'- (2'-phosphonylmethoxyethyl) adenine. Journal of Biological Chemistry, 2003, 278(32): 29509-29514.[31]Karin M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Current Opinion in Cell Biology, 1994, 6: 415-424.[32]Copsel S, Garcia C, Diez F, Vermeulem M, Baldi A, Bianciotti L G, Russel F G, Shayo C, Davio C. Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. Journal of Biological Chemistry, 2011, 286(9): 6979-6988.[33]Hammond C L, Marchan R, Krance S M, Ballatori N. Glutathione export during apoptosis requires functional multidrug resistance- associated proteins. Journal of Biological Chemistry, 2007, 282(19): 14337-14347.[34]Hammond C L, Lee T K, Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. Journal of Hepatology, 2001, 34: 946-954.[35]Coppola S, Ghibelli L. GSH extrusion and and the mitochondrial pathway of apoptotic signalling. Biochemical Society Transactions, 2000, 28(2): 56-61.[36]Tagami M, Kusuhara S, Imai H, Uemura A, Honda S, Tsukahara Y, Negi A. MRP4 knockdown enhances migration, suppresses apoptosis, and produces aggregated morphology in human retinal vascular endothelial cells. Biochemical Biophysical Research Communications, 2010, 400: 593-598.[37]Hannivoort R A, Dunning S, Vander Borght S, Schroyen B, Woudenberg J, Oakley F, Buist-Homan M, van den Heuvel F A, Geuken M, Geerts A, Roskams T, Faber K N, Moshage H. Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells. Hepatology, 2008, 48: 624-634.[38]Ciosk R, Shirayama M, Shevchenko A, Tanaka T, Toth A, Nasmyth K. Cohesin's binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins. Molecuar Cell, 2000, 5: 243-254.[39]Gillespie P J, Hirano T. Scc2 couples replication licensing to sister chromatid cohesion in Xenopus egg extracts. Current Biology, 2004, 14: 1598-1603.[40]Takahashi T S, Yiu P, Chou M F, Gygi S, Walter J C. Recruitment of Xenopus Scc2 and cohesin to chromatin requires the pre-replication complex. Nature Cell Biology, 2004, 6(10): 991-996.[41]Watrin E, Schleiffer A, Tanaka K, Eisenhaber F, Nasmyth K, Peters J M. Human Scc4 is required for cohesin binding to chromatin, sister-chromatid cohesion, and mitotic progression. Current Biology, 2006, 16(9): 863-874.[42]单士刚, 姚青, 彭建新, 洪华珠. 动物病毒诱导的细胞凋亡及其生理意义. 病毒学报, 2006, 22(3): 233-236.Shan S G, Yao Q, Peng J X, Hong H Z. Physiological significance of apoptosis in animal virus infection. Chinese Journal of Virology, 2006, 22(3): 233-236. (in Chinese) |